Media Summary: Explore the critical importance of including diverse The first of two Q&A discussion panels for day three of the The first of two Q&A discussion panels for day one of the

Citc 2024 D1s06 Specific Populations In Clinical Trials - Detailed Analysis & Overview

Explore the critical importance of including diverse The first of two Q&A discussion panels for day three of the The first of two Q&A discussion panels for day one of the Learn the essential principles behind rigorous This presentation provided a comprehensive overview of FDA's Bioresearch Monitoring (BIMO) Program and discussed the Good ... This presentation described the purposes, focuses, and types of

The final Q&A discussion panel for day two of the The first of three Q&A discussion panels for day two of the This presentation discussed FDA's perspective on Discover the critical safety principles that guide the earliest stages of human drug The second of two Q&A discussion panels for day one of the This presentation explored how electronic technologies are revolutionizing

This presentation explored FDA's origins from the Pure Food and Drug Act of 1906 to today's comprehensive regulatory ... This annual training course provided participants with the essential knowledge and skills to conduct This presentation described significant changes in the Explore the essential statistical concepts that form the backbone of reliable

Photo Gallery

CITC 2024 – D1S06 – Specific Populations in Clinical Trials
CITC 2024 – D3S04 – Q&A Discussion Panel 1
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)
CITC 2024 – D1S04 – Q&A Discussion Panel 1
CITC 2024 – D1S02 – Basics of Clinical Trial Design
CITC 2024 – D3S05 – FDA’s Good Clinical Practice Compliance Review for NDAs and BLAs
CITC 2024 – D3S06 – Clinical Investigator Inspection Readiness
CITC 2024 – D2S10 – Q&A Discussion Panel 3
CITC 2024 – D2S04 – Q&A Discussion Panel 1
CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality
CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development
CITC 2024 – D2S03 – Clinical Pharmacology: Early Drug Development
Sponsored
Sponsored
View Detailed Profile
CITC 2024 – D1S06 – Specific Populations in Clinical Trials

CITC 2024 – D1S06 – Specific Populations in Clinical Trials

Explore the critical importance of including diverse

CITC 2024 – D3S04 – Q&A Discussion Panel 1

CITC 2024 – D3S04 – Q&A Discussion Panel 1

The first of two Q&A discussion panels for day three of the

Sponsored
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

This course aims to prepare

CITC 2024 – D1S04 – Q&A Discussion Panel 1

CITC 2024 – D1S04 – Q&A Discussion Panel 1

The first of two Q&A discussion panels for day one of the

CITC 2024 – D1S02 – Basics of Clinical Trial Design

CITC 2024 – D1S02 – Basics of Clinical Trial Design

Learn the essential principles behind rigorous

Sponsored
CITC 2024 – D3S05 – FDA’s Good Clinical Practice Compliance Review for NDAs and BLAs

CITC 2024 – D3S05 – FDA’s Good Clinical Practice Compliance Review for NDAs and BLAs

This presentation provided a comprehensive overview of FDA's Bioresearch Monitoring (BIMO) Program and discussed the Good ...

CITC 2024 – D3S06 – Clinical Investigator Inspection Readiness

CITC 2024 – D3S06 – Clinical Investigator Inspection Readiness

This presentation described the purposes, focuses, and types of

CITC 2024 – D2S10 – Q&A Discussion Panel 3

CITC 2024 – D2S10 – Q&A Discussion Panel 3

The final Q&A discussion panel for day two of the

CITC 2024 – D2S04 – Q&A Discussion Panel 1

CITC 2024 – D2S04 – Q&A Discussion Panel 1

The first of three Q&A discussion panels for day two of the

CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality

CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality

This presentation discussed FDA's perspective on

CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development

CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development

Discover the critical safety principles that guide the earliest stages of human drug

CITC 2024 – D2S03 – Clinical Pharmacology: Early Drug Development

CITC 2024 – D2S03 – Clinical Pharmacology: Early Drug Development

This presentation defined

CITC 2024 – D1S07 – Q&A Discussion Panel 2

CITC 2024 – D1S07 – Q&A Discussion Panel 2

The second of two Q&A discussion panels for day one of the

CITC 2024 – D2S05 – Innovative Approaches to Clinical Trials

CITC 2024 – D2S05 – Innovative Approaches to Clinical Trials

This presentation explored how electronic technologies are revolutionizing

CITC 2024 – D1S01 – FDA Structure and Mandate

CITC 2024 – D1S01 – FDA Structure and Mandate

This presentation explored FDA's origins from the Pure Food and Drug Act of 1906 to today's comprehensive regulatory ...

FDA Clinical Investigator Training Course (CITC) 2024 (Day 2 of 3)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 2 of 3)

This course aims to prepare

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One

This annual training course provided participants with the essential knowledge and skills to conduct

CITC 2024 – D3S07 – FDA’s Use of Alternative Approaches to Evaluate GCP Compliance

CITC 2024 – D3S07 – FDA’s Use of Alternative Approaches to Evaluate GCP Compliance

This presentation described significant changes in the

CITC 2024 – D1S03 – Statistical Principles for Clinical Development

CITC 2024 – D1S03 – Statistical Principles for Clinical Development

Explore the essential statistical concepts that form the backbone of reliable

FDA Clinical Investigator Training Course (CITC) 2024 (Day 3 of 3)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 3 of 3)

This course aims to prepare